home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

5th Annual Drug Development Congress 2013

 
  February 04, 2013  
     
 
Oxford Global Conferences, Geneva, Switzerland
10th&11th June 2013


Agenda

Day 1 – Drug Development: Overcoming Key Challenges

  • Safety & Toxicity Assessment
  • Predicting Human Pharmacokinetics
  • Translational Modelling Approaches
  • Developing Biologics: Safety & Immunogenicity Concerns
  • Assay Development & Validation
  • NGS Applications For Drug Development

Day 2 – Improving Decision Making & Fostering Collaboration

  • Breaking Down Boundaries Between Discovery & Development
  • Improving Decision Making Through Biomarkers & Imaging
  • Integrating Toxicology Studies Earlier In The Pipeline
  • External Collaboration: Public/Private Collaboration
  • Internal Collaboration: Translating Data And Transferring Processes
 
 
Organized by: Oxford Global Conferences
Invited Speakers:

Confirmed speakers:

  • Bhupinder Bhullar
    Lab Head, Development Molecular Pathways, Novartis
  • Simon Chivers

    Senior Safety Assessment Expert, Novartis

  • Andreas Czich
    Head Preclinical Safety Germany, Sanofi
  • Sjef De Kimpe
    VP Early Drug Development, Prosensa
  • Stefania Di Marco,
    Senior Research Fellow, Okairos
  • Nicholas Ferenc,
    Director, Personalized Medicine and Companion Diagnostics Strategy, Sanofi
  • Peter Greasley
    Translational Science Director, AstraZeneca
  • Andrea Greiter-Wilke
    Head Safety Pharmacology, Roche
  • Joachim Höechel
    Head Clinical Pharmacokinetics WH/STH/CMR, Bayer HealthCare
  • Joel Krauser
    Director - DMPK/Isotope Laboratories (EU), Novartis
  • Thierry Lave
    Head DMPK Modeling and Simulation, Roche
  • Tom Loughman

    Director of API Development, Ipsen

  • Tomas Mow
    Head of Department Exploratory Toxicology, H. Lundbeck A/S
  • John Pears
    Director, Safety Science, AstraZeneca
  • Francois Pognan
    Executive Director - Biochemical & Translational Safety, Novartis
  • Prakesh Purohit,
    Associate Director, Scientific Affairs, Ipsen
  • Will Spooren
    Group Leader Behavioural Pharmacology, Roche
  • Robert Williams,
    Chief Drug Development Scientist, Cancer Research UK
 
Deadline for Abstracts: NA
 
Registration: For more information and to register: http://www.drugdevelopment-congress1.com/download-agenda/
E-mail: d.meredith@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.